Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. Issue 8 (August 2020)
- Record Type:
- Journal Article
- Title:
- Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. Issue 8 (August 2020)
- Main Title:
- Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series
- Authors:
- Böhmer, Merle M
Buchholz, Udo
Corman, Victor M
Hoch, Martin
Katz, Katharina
Marosevic, Durdica V
Böhm, Stefanie
Woudenberg, Tom
Ackermann, Nikolaus
Konrad, Regina
Eberle, Ute
Treis, Bianca
Dangel, Alexandra
Bengs, Katja
Fingerle, Volker
Berger, Anja
Hörmansdorfer, Stefan
Ippisch, Siegfried
Wicklein, Bernd
Grahl, Andreas
Pörtner, Kirsten
Muller, Nadine
Zeitlmann, Nadine
Boender, T Sonia
Cai, Wei
Reich, Andreas
an der Heiden, Maria
Rexroth, Ute
Hamouda, Osamah
Schneider, Julia
Veith, Talitha
Mühlemann, Barbara
Wölfel, Roman
Antwerpen, Markus
Walter, Mathias
Protzer, Ulrike
Liebl, Bernhard
Haas, Walter
Sing, Andreas
Drosten, Christian
Zapf, Andreas
… (more) - Abstract:
- Summary: Background: In December, 2019, the newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a respiratory disease presenting with fever, cough, and often pneumonia. WHO has set the strategic objective to interrupt spread of SARS-CoV-2 worldwide. An outbreak in Bavaria, Germany, starting at the end of January, 2020, provided the opportunity to study transmission events, incubation period, and secondary attack rates. Methods: A case was defined as a person with SARS-CoV-2 infection confirmed by RT-PCR. Case interviews were done to describe timing of onset and nature of symptoms and to identify and classify contacts as high risk (had cumulative face-to-face contact with a confirmed case for ≥15 min, direct contact with secretions or body fluids of a patient with confirmed COVID-19, or, in the case of health-care workers, had worked within 2 m of a patient with confirmed COVID-19 without personal protective equipment) or low risk (all other contacts). High-risk contacts were ordered to stay at home in quarantine for 14 days and were actively followed up and monitored for symptoms, and low-risk contacts were tested upon self-reporting of symptoms. We defined fever and cough as specific symptoms, and defined a prodromal phase as the presence of non-specific symptoms for at least 1 day before the onset of specific symptoms. Whole genome sequencing was used to confirm epidemiological links and clarifySummary: Background: In December, 2019, the newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a respiratory disease presenting with fever, cough, and often pneumonia. WHO has set the strategic objective to interrupt spread of SARS-CoV-2 worldwide. An outbreak in Bavaria, Germany, starting at the end of January, 2020, provided the opportunity to study transmission events, incubation period, and secondary attack rates. Methods: A case was defined as a person with SARS-CoV-2 infection confirmed by RT-PCR. Case interviews were done to describe timing of onset and nature of symptoms and to identify and classify contacts as high risk (had cumulative face-to-face contact with a confirmed case for ≥15 min, direct contact with secretions or body fluids of a patient with confirmed COVID-19, or, in the case of health-care workers, had worked within 2 m of a patient with confirmed COVID-19 without personal protective equipment) or low risk (all other contacts). High-risk contacts were ordered to stay at home in quarantine for 14 days and were actively followed up and monitored for symptoms, and low-risk contacts were tested upon self-reporting of symptoms. We defined fever and cough as specific symptoms, and defined a prodromal phase as the presence of non-specific symptoms for at least 1 day before the onset of specific symptoms. Whole genome sequencing was used to confirm epidemiological links and clarify transmission events where contact histories were ambiguous; integration with epidemiological data enabled precise reconstruction of exposure events and incubation periods. Secondary attack rates were calculated as the number of cases divided by the number of contacts, using Fisher's exact test for the 95% CIs. Findings: Patient 0 was a Chinese resident who visited Germany for professional reasons. 16 subsequent cases, often with mild and non-specific symptoms, emerged in four transmission generations. Signature mutations in the viral genome occurred upon foundation of generation 2, as well as in one case pertaining to generation 4. The median incubation period was 4·0 days (IQR 2·3–4·3) and the median serial interval was 4·0 days (3·0–5·0). Transmission events were likely to have occurred presymptomatically for one case (possibly five more), at the day of symptom onset for four cases (possibly five more), and the remainder after the day of symptom onset or unknown. One or two cases resulted from contact with a case during the prodromal phase. Secondary attack rates were 75·0% (95% CI 19·0–99·0; three of four people) among members of a household cluster in common isolation, 10·0% (1·2–32·0; two of 20) among household contacts only together until isolation of the patient, and 5·1% (2·6–8·9; 11 of 217) among non-household, high-risk contacts. Interpretation: Although patients in our study presented with predominately mild, non-specific symptoms, infectiousness before or on the day of symptom onset was substantial. Additionally, the incubation period was often very short and false-negative tests occurred. These results suggest that although the outbreak was controlled, successful long-term and global containment of COVID-19 could be difficult to achieve. Funding: All authors are employed and all expenses covered by governmental, federal state, or other publicly funded institutions. … (more)
- Is Part Of:
- Lancet infectious diseases. Volume 20:Issue 8(2020)
- Journal:
- Lancet infectious diseases
- Issue:
- Volume 20:Issue 8(2020)
- Issue Display:
- Volume 20, Issue 8 (2020)
- Year:
- 2020
- Volume:
- 20
- Issue:
- 8
- Issue Sort Value:
- 2020-0020-0008-0000
- Page Start:
- 920
- Page End:
- 928
- Publication Date:
- 2020-08
- Subjects:
- Communicable diseases -- Periodicals
Infection -- Periodicals
Communicable Diseases -- Periodicals
Infection -- Periodicals
Maladies infectieuses -- Périodiques
Infection -- Périodiques
Communicable diseases
Infection
Periodicals
616.905 - Journal URLs:
- http://www.mdconsult.com/public/search?search_type=journal&j_sort=pub_date&j_issn=1473-3099 ↗
http://www.sciencedirect.com/science/journal/14733099 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S1473-3099(20)30314-5 ↗
- Languages:
- English
- ISSNs:
- 1473-3099
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.082000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13687.xml